Insider · CIK 0001128484
John Chidsey
Files at EHC (Encompass Health Corp), HCA (HCA Healthcare, Inc.), NCLH (Norwegian Cruise Line Holdings Ltd.). First filing May 26, 2026, latest May 26, 2026.
In brief
John Chidsey files SEC Form 4 as director, CEO and president at NCLH (Norwegian Cruise Line Holdings Ltd.), and also at EHC (Encompass Health Corp), HCA (HCA Healthcare, Inc.). Since May 26, 2026, John Chidsey has reported 1 open-market buy worth $2.5M and 0 open-market sells worth $0, the latest filed on May 26, 2026.
A track record needs three past buys with six months of prices behind them; John Chidsey has 0, so none is measured yet.
The newest scored trade: bought $2.5M of NCLH on May 22, 2026, filed May 26, 2026, scored 76 (notable). In the last 12 months: 1 buy worth $2.5M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NCLH: Norwegian Cruise Line Holdings Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 76Notable | Norwegian Cruise Line Holdings Ltd. | $2.5M 153,000 shares | +16% | +10% from low-40% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | NCLH Norwegian Cruise Line Holdings Ltd. | POpen-market purchase Common Stock | +153,000 | $16.37 | $2.5M | 1,139,940 | May 26, 2026 |
| Apr 28, 2026 | HCA HCA Healthcare, Inc. | AGrant or award Common Stock | +809 | $0.00 | $0 | 1,305 | Apr 30, 2026 |
| Mar 26, 2026 | NCLH Norwegian Cruise Line Holdings Ltd. | AGrant or award Common Stock | +967,254 | $0.00 | $0 | 986,940 | Mar 27, 2026 |
| Mar 26, 2026 | NCLH Norwegian Cruise Line Holdings Ltd. | AGrant or award Performance Share Unitsderivative | +1,172,638 | $0.00 | $0 | 1,172,638 | Mar 27, 2026 |
| Jan 2, 2026 | NCLH Norwegian Cruise Line Holdings Ltd. | AGrant or award Common Stock | +13,169 | $0.00 | $0 | 19,686 | Jan 6, 2026 |
| Jul 29, 2025 | HCA HCA Healthcare, Inc. | AGrant or award Common Stock | +496 | $0.00 | $0 | 496 | Jul 31, 2025 |
| Feb 5, 2025 | NCLH Norwegian Cruise Line Holdings Ltd. | AGrant or award Common Stock | +6,517 | $0.00 | $0 | 6,517 | Feb 7, 2025 |
| Oct 16, 2023 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +222 | $0.00 | $0 | 161,181 | Oct 17, 2023 |
| Oct 17, 2023 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +541 | $64.58 | $35k | 161,722 | Oct 17, 2023 |
Questions about John Chidsey
Answered from the filings on this page, as of the latest one.
Is John Chidsey buying or selling?
In the last 12 months John Chidsey reported 1 open-market buy worth $2.5M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $2.5M of NCLH on May 22, 2026. Grants, option exercises and tax withholding are not counted.
How did John Chidsey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Chidsey has 0.
Where does John Chidsey file Form 4?
John Chidsey has filed Form 4 at NCLH (Norwegian Cruise Line Holdings Ltd.) as President and CEO; EHC (Encompass Health Corp); HCA (HCA Healthcare, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.